Analyst average price targets imply a potential 39.9% upside for vTv Therapeutics (VTVT). The article flags the price-target metric as of questionable effectiveness but notes a positive trend in earnings estimate revisions that could support upside in the stock.
Analyst average price targets imply a potential 39.9% upside for vTv Therapeutics (VTVT). The article flags the price-target metric as of questionable effectiveness but notes a positive trend in earnings estimate revisions that could support upside in the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
